<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of the present study was to evaluate the function of granulocytes in 20 patients affected by <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and correlate this with the expression of surface membrane integrins </plain></SENT>
<SENT sid="1" pm="."><plain>The granulocytes showed a deficit in chemotaxis (34 +/- 12 vs 84 +/- 10, p &lt; 0.01) in <z:chebi fb="1" ids="18421">superoxide</z:chebi> release (12 +/- 7 vs 30 +/- 10, p &lt; 0.01) and in aggregation 12 +/- 6 vs 36 +/- 9, p &lt; 0.01 using <z:chebi fb="0" ids="53490">fMLP</z:chebi> as stimulus </plain></SENT>
<SENT sid="2" pm="."><plain>We also demonstrated with cytofluorimetric and alkaline phosphatase immunoenzymatic analysis (APAAP), decreased expression of CD11b/CD18 receptor detected by OKM1 (p &lt; 0.001) and CD18 detected by MoAb IOT-18 (p &lt; 0.001) </plain></SENT>
<SENT sid="3" pm="."><plain>PMNs CD11b/CD18 up-regulation and APAAP image analysis studies showed a lower level of expression of CD11b/CD18 in granulocytes from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients compared to controls (p &lt; 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>We concluded that <z:mp ids='MP_0002462'>granulocyte dysfunction</z:mp> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> may be correlated with modification of leukocyte integrins </plain></SENT>
</text></document>